Cargando…
Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. Despite improvements in treatment, CLL is still considered an incurable disease. The aim of the present study was to evaluate galectin-1, −3 and −9 (Gal-1, −3 and −9) and Gal-3 binding protein (Gal-3BP) as prognostic a...
Autores principales: | Wdowiak, Kamil, Gallego-Colon, Enrique, Francuz, Tomasz, Czajka-Francuz, Paulina, Ruiz-Agamez, Natalia, Kubeczko, Marcin, Grochoła, Iga, Wybraniec, Maciej T., Chudek, Jerzy, Wojnar, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313089/ https://www.ncbi.nlm.nih.gov/pubmed/30655861 http://dx.doi.org/10.3892/ol.2018.9656 |
Ejemplares similares
-
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
por: Wdowiak, Kamil, et al.
Publicado: (2018) -
C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation
por: Kubeczko, Marcin, et al.
Publicado: (2016) -
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
por: Czajka-Francuz, Paulina, et al.
Publicado: (2021) -
The Value of Prolactin, a Panel of Cytokines, and the Soluble Human Epidermal Growth Factor Receptor 2 in the Prediction of Rapid Progression and Shorter Survival during Palliative Chemotherapy of Colorectal Cancer Patients
por: Cisoń-Jurek, Sylwia, et al.
Publicado: (2023) -
Vitamin D and Its Metabolites Status before and during Chemotherapy in Caucasian Breast Cancer Patients
por: Kimsa-Furdzik, Małgorzata, et al.
Publicado: (2023)